Session Details

Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted By GE Healthcare)
Thursday, May 30, 2019 12:30 PM - 01:30 PM 
Room 219
Phil Vanek, PhD,GM, Growth Strategy, GEHC Cell and Gene Therapy, United States

Robin Ng, PhD, Strategy Lead, Technology and Manufacturing, Cellular Biomedicine Group, China

Rohin Iyer, PhD, Development Manager, Cell and Gene Therapy, GEHC/FastTrak@CCRM, Canada

Greg Crescenzi Enterprise Solutions Leader, GEHC Cell and Gene Therapy, United States

Effective process development and robust manufacturing are key to scaling cell and gene therapies for commercialization. A flexible solution that offers both could provide a competitive advantage. Recently, Cellular Biomedicine Group (CBMG), a clinical stage biopharmaceutical company in Shanghai, China, partnered with GE Healthcare (GEHC)’s Enterprise Solutions team as well as the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto to develop a next-generation CAR-T process based on GE’s FlexFactory equipment. Through a panel discussion they will discuss how these three teams worked together, with specific emphasis on how important logistical, technical and communication decisions were made to build a state-of-the-art CAR-T manufacturing facility/process that met CBMG’s specifications and supported their IND filing to the Chinese FDA.

Philip Vanek PhD
GM Cell and Gene Therapy Strategy
GE Healthcare

Greg Crescenzi
Enterprise Solutions Leader
GE Healthcare

Rohin Iyer
Development Manager
GE Healthcare

Robin Ng PhD
Strategy Lead, Technology & Manufacturing
Cellular Biomedicine Group